The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $84.46

Today's change-0.42 -0.49%
Updated September 28 10:44 AM EDT. Delayed by at least 15 minutes.
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $84.46

Today's change-0.42 -0.49%
Updated September 28 10:44 AM EDT. Delayed by at least 15 minutes.

Quest Diagnostics Inc down (U.S.)$0.42

Quest Diagnostics Inc is lower today, dropping (U.S.)$0.42 or 0.49% to (U.S.)$84.46. Shares have lost 0.47% over the last five days, but sit 2.75% below their 52-week high. This security has outperformed the S&P 500 by 24.87% during the last year.

Key company metrics

  • Open(U.S.) $84.88
  • Previous close(U.S.) $84.88
  • High(U.S.) $85.06
  • Low(U.S.) $84.43
  • Bid / Ask(U.S.) $84.44 / (U.S.) $84.46
  • YTD % change+18.72%
  • Volume119,813
  • Average volume (10-day)952,757
  • Average volume (1-month)1,197,805
  • Average volume (3-month)1,200,351
  • 52-week range(U.S.) $59.66 to (U.S.) $86.85
  • Beta0.69
  • Trailing P/E14.78×
  • P/E 1 year forward16.62×
  • Forward PEG2.13×
  • Indicated annual dividend(U.S.) $1.60
  • Dividend yield1.89%
  • Trailing EPS(U.S.) $5.72
Updated September 28 10:44 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.46%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue1,9061,8631,8491,880
Total other revenue--------
Total revenue1,9061,8631,8491,880
Gross profit753720702730
Total cost of revenue1,1531,1431,1471,150
Total operating expense1,4841,6061,6101,249
Selling / general / administrative429440429399
Research & development--------
Depreciation / amortization17192020
Interest expense (income), net operating--------
Unusual expense (income)-11533-319
Other operating expenses, total0111-1
Operating income422257239631
Interest income (expense), net non-operating-35---36-35
Gain (loss) on sale of assets--------
Other--------
Income before tax392182214593
Income after tax209114200354
Income tax, total1836814239
Net income195102188342
Total adjustments to net income-100-2
Net income before extra. items195102188342
Minority interest-14-12-12-12
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items194102188340
Inc. avail. to common incl. extra. items194102188340
Diluted net income194102188340
Dilution adjustment--------
Diluted weighted average shares142144145145
Diluted EPS excluding extraordinary itemsvalue per share1.370.711.302.34
Dividends per sharevalue per share0.400.400.380.38
Diluted normalized EPSvalue per share0.930.721.321.03